THBS1 and glioblastoma: This preliminary finding provides further evidence that gabapentin-mediated TSP-1 inhibition (corresponding to reduction of peripheral TSP-1) impairs the proliferation of GBM, which in previous work targeted cell subpopulations within intratumoral regions with high connectivity.